Home / Business / The Dow tumbles 200 points as the stock market sells; Apple hit with antitrust lawsuit

The Dow tumbles 200 points as the stock market sells; Apple hit with antitrust lawsuit

Major market indices extended their midday losses on Friday, with the Dow Jones industrial average falling more than 200 points as Chevron and Apple weighed in.


The S&P 500 fell more than 0.6%, the Dow Jones industry was down 0.6% and the Nasdaq gave up nearly 0.5% in the stock market today. Small caps, followed by the Russell 2000, were down 0.8%, trading volume fell on both major exchanges against the same time on Thursday.

For this week, the Nasdaq and S&P 500 are in for a slight rally, but the Dow is headed for a 0.7% loss.

In 2020, tech stocks helped the Nasdaq gain 43.6%, the fifth-best year ever, the S&P 500 was up 16.3% in 2020 and the Dow was up 7.2% after a strong start in This year and a brief correction, the market has rebounded to near record highs. Read the big picture for a detailed daily market analysis.


The COVID-19 epidemic has plagued the US economy as the nationwide blockade has now passed over a year. But many states are easing the restrictions, and cases are beginning to decline or decrease in some states with vaccinations.

Overview of the US stock market today

index The symbol price Profit / loss % Change
Dow (0DJIA) 33845.33 -215.03 -0.63
S&P 500 (0S and P5) 4185.72 -25.75 -0.61
Nasdaq (0NDQC) 14017.26 -65.29 -0.46
Russell 2000 (Etc.) 226.22 -1.77 -0.78
IBD 50 (FFTY) 46.70 -0.50 -1.06
Last Update: 12:08 PM ET 4/30/2021

The cumulative number of COVID-19 cases worldwide is as high as 151 million, with more than 3 million deaths, according to Worldometer.In the United States, there are more than 33 million cases and more than 589,000 deaths, although the number of new cases has been reported. In the US, it will slow down significantly in many states.

As countries rush to vaccinate their people Pfizer (PFE) Affiliate Biotech (BNTX) increased 6% in heavy trading to reach new highs. The stock is currently up approximately 46% from the 131.10 buy point of the consolidation.

modern (MRNA), in which the Covid-19 vaccine is also approved for FDA emergency use, increased 3.5%. The biotech stock is about 4% away from the 189.36 point of purchase of the cup base. Moderna aims to produce the vaccine in On April 29, the company expects to produce 800 million to 1 billion doses of the vaccine this year and 3 billion next year.

Dow Jones Movers

Chevron (CVX) fell and slipped 3% in heavy volumes to test the 50-day moving average.The stock was operating on a seven-week flat with 112.80 points of buy, according to marketSmith chart analysis, Chevron stocks were roughly 7% off the list.

The oil giant reported mixed Q1 earnings early Friday due to missed results. But top sales earned 90 cents per share on revenue of $ 31.7 billion.Analysts had expected 95 cents on revenue of $ 30.9 billion.

Among the other blue chip losers Dow Inc. (DOW) and IBM (IBM) decreased by more than 2% per department. Cisco Systems (CSCO) and visa (V) Surrender almost 2% per person.

An apple (AAPL), which reduced the previous greater losses to 0.4%, is moving towards a fourth straight decline. The stock was slightly below the cup’s 135.63 buy point, with the deal briefly cleared Thursday.Apple reported its quarterly results late Wednesday.

European Commission attacks Apple with antitrust charges for publishing music streaming apps. That could lead to fines of up to 10% of the iPhone maker’s total annual revenue and changes to the App store rules.

Include blue chip receiver Amgen (AMGN) and Merck (MRK) increased by more than 1% per transaction.

Outside the Dow

Oil and gas, solar and travel reserves have plunged the IBD’s 197 industrial clusters.Carmakers, steel and utility stocks were among the few that fell.

In the automobile manufacturers Tesla (TSLA) is up nearly 4% in rapid turnover to seize the 50-day line.The stock is building the right side of the new cup with a handle, offering a 780.89 buy point, but a downward base.

Amazon (AMZN) rose 2% in large volume, ready to expand its winning streak to six.Amazon’s stock remained in the range of a potential buy from 3,436.03 points of purchase, the highest buy zone of 3,607.83 items slightly higher, waiting at 3,552.35. Slightly above the left high

As late as Thursday, the e-commerce giant reported a Q1 performance that beat Wall Street targets both above and below.Amazon delivered an adjusted profit of $ 15.79 per share on revenue of $ 108.5 billion. Analysts had expected $ 9.54 on revenue of $ 104.5 billion, according to FactSet.Amazon also received guidance for higher-than-expected Q2 revenue.

AstraZeneca soars

AstraZeneca (AZN) gained almost 5 percent in rapid turnover, seizing the 200-day production line for the first time since January.AstraZeneca shares remained about 17 percent from their 52-week high.

The UK drugmaker’s Q1 results saw high views due to strong sales of cancer drugs. The coronavirus vaccine also has sales of $ 275 million, but the increased guidance for 2021 excludes the effects of the AstraZeneca vaccine sells the COVID vaccine outside the United States.

The Innovator IBD 50 ETF (FFTY) fell 1%, with its fourth consecutive drop. BioNTech and Cricut (CRCT) increased by more than 5% per unit, but 360 DigiTech (QFIN), At Home Group (HOME) and Louisiana Pacific (LPX) weighed

Follow Nancy Gondo on Twitter @IBD_NGondo.

You may also like:

Best Dividend Stock: Get Quadruple Market Return

Find today’s best growing stocks to watch with IBD 50.

Learn how to time the markets with the IBD ETF Markets Strategy.

See stocks on the market leader list with the IBD Leaderboard.

Source link